Recent studies have demonstrated the significant role of PI3Kβ in activating the PI3K/AKT pathway in CRPC with PTEN deletion, indicating that targeting PI3kβ inhibitors is a crucial strategy for advanced de‐castration‐resistant PCa [41]. The gene discussed is PIK3CA; the disease is posterior cortical atrophy.